Protagonist Therapeutics: 3Q Earnings Snapshot

November 6, 2018

NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Tuesday reported a loss of $8.7 million in its third quarter.

The Newark, California-based company said it had a loss of 38 cents per share.

The biopharmaceutical company posted revenue of $6.1 million in the period.

Protagonist Therapeutics shares have dropped 58 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $8.69, a drop of 41 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX

Update hourly